Details
Stereochemistry | RACEMIC |
Molecular Formula | C8H11NO2.ClH |
Molecular Weight | 189.639 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.NCC(O)C1=CC(O)=CC=C1
InChI
InChIKey=OWMFSWZUAWKDRR-UHFFFAOYSA-N
InChI=1S/C8H11NO2.ClH/c9-5-8(11)6-2-1-3-7(10)4-6;/h1-4,8,10-11H,5,9H2;1H
DescriptionSources: http://www.ndrugs.com/?s=norfenefrineCurator's Comment: Description was created based on several sources, including http://www.kegg.jp/entry/D08286 and http://www.ncbi.nlm.nih.gov/pubmed/6351455
Sources: http://www.ndrugs.com/?s=norfenefrine
Curator's Comment: Description was created based on several sources, including http://www.kegg.jp/entry/D08286 and http://www.ncbi.nlm.nih.gov/pubmed/6351455
Norfenefrine or meta-octopamine, also known as 3,β-dihydroxyphenethylamine, is an adrenergic agent used as a sympathomimetic drug which is marketed in Europe, Japan, and Mexico. Along with its structural isomer p-octopamine and the tyramines, norfenefrine is a naturally occurring, endogenous trace amine and plays a role as a minor neurotransmitter in the brain. Norfenefrine controls blood pressure in acute hypotensive states eg pheochromocytomectomy, sympathectomy, poliomyelitis, spinal anesth, MI, septicemia, blood transfusion and drug reactions. Adjunct in treatment of cardiac arrest and hypotension.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094251 Sources: http://www.genome.jp/dbget-bin/www_bget?dr:D08286 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Nevadral Retard Approved UseIndications: hypotension |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/6150569
Curator's Comment: Can also be administered inramuscularly
http://www.ncbi.nlm.nih.gov/pubmed/7197979
For the treatment of female stress incontinence 60 mg were given in slow-release tablets.
Route of Administration:
Oral
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/6147146
At 0.1 and 1 umol/l, norfenefrine caused contractions of the rabbit pulmonary artery strips
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29709
Created by
admin on Fri Dec 15 15:18:28 GMT 2023 , Edited by admin on Fri Dec 15 15:18:28 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID1046710
Created by
admin on Fri Dec 15 15:18:28 GMT 2023 , Edited by admin on Fri Dec 15 15:18:28 GMT 2023
|
PRIMARY | |||
|
CHEMBL358040
Created by
admin on Fri Dec 15 15:18:28 GMT 2023 , Edited by admin on Fri Dec 15 15:18:28 GMT 2023
|
PRIMARY | |||
|
20907
Created by
admin on Fri Dec 15 15:18:28 GMT 2023 , Edited by admin on Fri Dec 15 15:18:28 GMT 2023
|
PRIMARY | |||
|
236468
Created by
admin on Fri Dec 15 15:18:28 GMT 2023 , Edited by admin on Fri Dec 15 15:18:28 GMT 2023
|
PRIMARY | RxNorm | ||
|
1473206
Created by
admin on Fri Dec 15 15:18:28 GMT 2023 , Edited by admin on Fri Dec 15 15:18:28 GMT 2023
|
PRIMARY | |||
|
15308-34-6
Created by
admin on Fri Dec 15 15:18:28 GMT 2023 , Edited by admin on Fri Dec 15 15:18:28 GMT 2023
|
SUPERSEDED | |||
|
4779-94-6
Created by
admin on Fri Dec 15 15:18:28 GMT 2023 , Edited by admin on Fri Dec 15 15:18:28 GMT 2023
|
PRIMARY | |||
|
C81364
Created by
admin on Fri Dec 15 15:18:28 GMT 2023 , Edited by admin on Fri Dec 15 15:18:28 GMT 2023
|
PRIMARY | |||
|
297582
Created by
admin on Fri Dec 15 15:18:28 GMT 2023 , Edited by admin on Fri Dec 15 15:18:28 GMT 2023
|
PRIMARY | |||
|
C005310
Created by
admin on Fri Dec 15 15:18:28 GMT 2023 , Edited by admin on Fri Dec 15 15:18:28 GMT 2023
|
PRIMARY | |||
|
100733
Created by
admin on Fri Dec 15 15:18:28 GMT 2023 , Edited by admin on Fri Dec 15 15:18:28 GMT 2023
|
PRIMARY | |||
|
m8058
Created by
admin on Fri Dec 15 15:18:28 GMT 2023 , Edited by admin on Fri Dec 15 15:18:28 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000085722
Created by
admin on Fri Dec 15 15:18:28 GMT 2023 , Edited by admin on Fri Dec 15 15:18:28 GMT 2023
|
PRIMARY | |||
|
239-351-1
Created by
admin on Fri Dec 15 15:18:28 GMT 2023 , Edited by admin on Fri Dec 15 15:18:28 GMT 2023
|
ALTERNATIVE | |||
|
1FCN9TAU6R
Created by
admin on Fri Dec 15 15:18:28 GMT 2023 , Edited by admin on Fri Dec 15 15:18:28 GMT 2023
|
PRIMARY | |||
|
SUB03459MIG
Created by
admin on Fri Dec 15 15:18:28 GMT 2023 , Edited by admin on Fri Dec 15 15:18:28 GMT 2023
|
PRIMARY | |||
|
225-323-6
Created by
admin on Fri Dec 15 15:18:28 GMT 2023 , Edited by admin on Fri Dec 15 15:18:28 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD